|
US5981568A
(en)
*
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
ES2098188B1
(es)
*
|
1995-05-11 |
1997-12-16 |
Univ Santiago Compostela |
Desarrollo de nanoparticulas a base de polimeros hidrofilicos.
|
|
US20010009904A1
(en)
*
|
1997-12-30 |
2001-07-26 |
Jon A. Wolff |
Process of delivering a polynucleotide to a cell via the vascular system
|
|
ATE216264T1
(de)
*
|
1996-07-10 |
2002-05-15 |
West Pharm Serv Drug Res Ltd |
Gentherapiesystem zur zielung des endotheliums
|
|
ES2114502B1
(es)
*
|
1996-07-29 |
1999-07-01 |
Univ Santiago Compostela |
Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.
|
|
US6649192B2
(en)
*
|
1996-07-29 |
2003-11-18 |
Universidade De Santiago De Compostela |
Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms
|
|
WO1998017317A2
(de)
*
|
1996-10-23 |
1998-04-30 |
Skw Trostberg Aktiengesellschaft |
Verfahren zur herstellung von biologisch aktiven polymernanopartikel-nucleinsäure-konjugaten
|
|
US6387700B1
(en)
|
1996-11-04 |
2002-05-14 |
The Reagents Of The University Of Michigan |
Cationic peptides, Cys-Trp-(LYS)n, for gene delivery
|
|
EP0860167A1
(de)
*
|
1997-01-30 |
1998-08-26 |
Robert Gurny |
DNA und RNA Wirkstoffderivate in Nanopartikeln
|
|
ATE235890T1
(de)
|
1997-01-30 |
2003-04-15 |
Chiron Corp |
Verwendung von mikropartikeln mit adsorbiertem antigen zur stimulierung der immunabwehr
|
|
EP1275380A1
(de)
*
|
1997-01-30 |
2003-01-15 |
Chiron Corporation |
Verwendung von Mikropartikeln mit adsorbiertem Antigen zur Stimulierung der Immunabwehr
|
|
US6884435B1
(en)
*
|
1997-01-30 |
2005-04-26 |
Chiron Corporation |
Microparticles with adsorbent surfaces, methods of making same, and uses thereof
|
|
WO1998043618A2
(en)
*
|
1997-03-31 |
1998-10-08 |
Neorx Corporation |
Use of cytoskeletal inhibitors for the prevention of restenosis
|
|
WO1998047492A1
(en)
*
|
1997-04-18 |
1998-10-29 |
Vertex Pharmaceuticals Incorporated |
Nanosized aspartyl protease inhibitors
|
|
US5885609A
(en)
*
|
1997-05-23 |
1999-03-23 |
Northeastern University |
Biocompatible articles and method for making same
|
|
DE59810105D1
(de)
*
|
1997-12-12 |
2003-12-11 |
Max Delbrueck Centrum |
Mittel zur gentherapie von tumorerkrankungen, neurodegenerativen, herzkreislauf- und autoimmunerkrankungen
|
|
US6254890B1
(en)
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
|
US6395253B2
(en)
*
|
1998-04-23 |
2002-05-28 |
The Regents Of The University Of Michigan |
Microspheres containing condensed polyanionic bioactive agents and methods for their production
|
|
KR19990085365A
(ko)
*
|
1998-05-16 |
1999-12-06 |
허영섭 |
지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
|
|
EP1091730A1
(de)
*
|
1998-06-29 |
2001-04-18 |
White Spot AG |
Verwendung von wachstumsfaktoren zur arzneimittelherstellung
|
|
IL125336A0
(en)
*
|
1998-07-14 |
1999-03-12 |
Yissum Res Dev Co |
Compositions for inhibition and treatment of restinosis
|
|
US7008645B2
(en)
*
|
1998-07-14 |
2006-03-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of inhibiting restenosis using bisphosphonates
|
|
DE69930642T2
(de)
*
|
1998-07-29 |
2006-12-28 |
Chiron Corp., Emeryville |
Mikropartikel mit adsorbenten oberflächen, verfahren zu ihrer herstellung und ihrer verwendung
|
|
WO2000012124A1
(en)
*
|
1998-09-01 |
2000-03-09 |
Elan Corporation, Plc |
Oral vaccine compositions
|
|
US7087236B1
(en)
|
1998-09-01 |
2006-08-08 |
Merrion Research I Limited |
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
|
|
EP1107783B1
(de)
*
|
1998-09-01 |
2006-04-05 |
ELAN CORPORATION, Plc |
Verfahren zur induktion der zellulären immunantwort und parenterale impfstoff-zusammensetzungen dazu
|
|
US6689121B1
(en)
*
|
1998-09-24 |
2004-02-10 |
C. R. Bard, Inc. |
Systems and methods for treating ischemia
|
|
US6251079B1
(en)
|
1998-09-30 |
2001-06-26 |
C. R. Bard, Inc. |
Transthoracic drug delivery device
|
|
US6458092B1
(en)
|
1998-09-30 |
2002-10-01 |
C. R. Bard, Inc. |
Vascular inducing implants
|
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
WO2000043044A1
(en)
*
|
1999-01-19 |
2000-07-27 |
The Children's Hospital Of Philadelphia |
Compositions and methods for controlled delivery of virus vectors
|
|
JP2003503308A
(ja)
*
|
1999-02-02 |
2003-01-28 |
セーフサイエンス インコーポレイテッド |
遺伝子治療の送達系及び方法
|
|
WO2000046147A2
(en)
|
1999-02-03 |
2000-08-10 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles and methods of manufacture and use
|
|
EP1471034A3
(de)
*
|
1999-02-03 |
2005-03-02 |
Biosante Pharmaceuticals, Inc. |
Therapeutische kalzium-phosphat Partikel und Methoden zu deren Herstellung und Verwendung
|
|
JP5124066B2
(ja)
*
|
1999-03-24 |
2013-01-23 |
イギリス国 |
ポリカチオン性炭水化物のワクチンにおける免疫賦活剤としての使用
|
|
US6620170B1
(en)
|
1999-04-26 |
2003-09-16 |
C. R. Bard, Inc. |
Devices and methods for treating ischemia by creating a fibrin plug
|
|
US6986784B1
(en)
|
1999-05-14 |
2006-01-17 |
C. R. Bard, Inc. |
Implant anchor systems
|
|
US6719805B1
(en)
|
1999-06-09 |
2004-04-13 |
C. R. Bard, Inc. |
Devices and methods for treating tissue
|
|
US6770740B1
(en)
|
1999-07-13 |
2004-08-03 |
The Regents Of The University Of Michigan |
Crosslinked DNA condensate compositions and gene delivery methods
|
|
US6277082B1
(en)
|
1999-07-22 |
2001-08-21 |
C. R. Bard, Inc. |
Ischemia detection system
|
|
US6629987B1
(en)
|
1999-07-30 |
2003-10-07 |
C. R. Bard, Inc. |
Catheter positioning systems
|
|
US6855160B1
(en)
|
1999-08-04 |
2005-02-15 |
C. R. Bard, Inc. |
Implant and agent delivery device
|
|
DE19961939A1
(de)
*
|
1999-12-22 |
2001-06-28 |
Cognis Deutschland Gmbh |
Verwendung von nanoskaligen kationischen Verbindungen
|
|
AU2002219944B2
(en)
|
2000-11-28 |
2008-02-21 |
Medimmune, Llc |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US7229619B1
(en)
|
2000-11-28 |
2007-06-12 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US7232421B1
(en)
|
2000-05-12 |
2007-06-19 |
C. R. Bard, Inc. |
Agent delivery systems
|
|
US7527807B2
(en)
|
2000-06-21 |
2009-05-05 |
Cubist Pharmaceuticals, Inc. |
Compositions and methods for increasing the oral absorption of antimicrobials
|
|
US7204847B1
(en)
|
2000-07-28 |
2007-04-17 |
C. R. Bard, Inc. |
Implant anchor systems
|
|
US7829100B2
(en)
|
2000-09-12 |
2010-11-09 |
Teagarden Dirk L |
Pharmaceutical composition having modified carrier
|
|
AUPR011700A0
(en)
|
2000-09-14 |
2000-10-05 |
Austin Research Institute, The |
Composition comprising immunogenic virus sized particles (VSP)
|
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
MXPA03002643A
(es)
|
2000-09-28 |
2003-06-19 |
Chiron Corp |
Composiciones de microparticulas y metodos para producirlas.
|
|
JP4516273B2
(ja)
*
|
2000-11-15 |
2010-08-04 |
ミナーヴァ・バイオテクノロジーズ・コーポレーション |
オリゴヌクレオチド識別子
|
|
US7179900B2
(en)
|
2000-11-28 |
2007-02-20 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US6818216B2
(en)
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
US6855493B2
(en)
|
2000-11-28 |
2005-02-15 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US7083784B2
(en)
|
2000-12-12 |
2006-08-01 |
Medimmune, Inc. |
Molecules with extended half-lives, compositions and uses thereof
|
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US7037528B2
(en)
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US6613083B2
(en)
|
2001-05-02 |
2003-09-02 |
Eckhard Alt |
Stent device and method
|
|
EP1389468A4
(de)
|
2001-05-23 |
2007-01-10 |
Tanabe Seiyaku Co |
Zusammensetzungen zur förderung der knochenfrakturheilung
|
|
CN1537018A
(zh)
|
2001-05-23 |
2004-10-13 |
田边制药株式会社 |
一种用于软骨疾病再生治疗的组合物
|
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
BR0212833A
(pt)
*
|
2001-09-26 |
2004-10-13 |
Baxter Int |
Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
|
|
US7112340B2
(en)
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
FR2836381B1
(fr)
*
|
2002-02-22 |
2004-09-10 |
Oreal |
Nanocapsules a base de polyester polyol, et compositions cosmetiques ou dermatologiques les contenant
|
|
DE10209860A1
(de)
*
|
2002-03-06 |
2003-09-25 |
Hemofarm Konzern A D |
Hydrophobe Nanotropfen mit gebundenen Hämoglobinmolekülen in hydrophiler Phase enthaltene Emulsion als Blutersatzstoff
|
|
US20050152980A1
(en)
*
|
2002-03-13 |
2005-07-14 |
Michael Ausborn |
Pharmeutical microparticles
|
|
JP2003342196A
(ja)
*
|
2002-05-31 |
2003-12-03 |
Mukku:Kk |
静脈注射用組成物、その製造法およびその製剤
|
|
US7425618B2
(en)
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
|
EP2283864A1
(de)
*
|
2002-07-16 |
2011-02-16 |
Elan Pharma International Ltd. |
Flüssige Zusammensetzung enthaltend stabilisierte Wirkstoff-Nanopartikeln
|
|
FR2842737B1
(fr)
*
|
2002-07-25 |
2006-01-27 |
Centre Nat Rech Scient |
Particules revetues en surface de hyaluronane ou d'un de ses derives et leur utilisation a titre de vecteurs biologiques pour des matieres actives
|
|
DK1534335T4
(en)
|
2002-08-14 |
2015-10-05 |
Macrogenics Inc |
FCGAMMARIIB-SPECIFIC ANTIBODIES AND PROCEDURES FOR USE THEREOF
|
|
BR0314450A
(pt)
|
2002-09-09 |
2005-07-26 |
Trigen Ltd |
Sais de ácido borÈnico com adição de uma base farmaceuticamente aceitável, formulação farmacêutica, e uso dos referidos sais para preparar uma formulação farmacêutica
|
|
US7659061B2
(en)
|
2002-11-19 |
2010-02-09 |
Pharmacia & Upjohn Company |
Pharmaceutical compositions having a modified vehicle
|
|
CA2512729C
(en)
|
2003-01-09 |
2014-09-16 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant fc regions and methods of using same
|
|
CA2512974A1
(en)
|
2003-01-13 |
2004-07-29 |
Macrogenics, Inc. |
Soluble fc.gamma.r fusion proteins and methods of use thereof
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
WO2004084871A1
(en)
*
|
2003-03-26 |
2004-10-07 |
Ltt Bio-Pharma Co., Ltd. |
Intravenous nanoparticles for targenting drug delivery and sustained drug release
|
|
AU2004229501B2
(en)
|
2003-04-11 |
2011-08-18 |
Medimmune, Llc |
Recombinant IL-9 antibodies and uses thereof
|
|
JP5557415B2
(ja)
|
2003-06-02 |
2014-07-23 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
吸着させたトキソイドおよび多糖類含有抗原を含む微粒子に基づく免疫原性組成物
|
|
US10517883B2
(en)
|
2003-06-27 |
2019-12-31 |
Zuli Holdings Ltd. |
Method of treating acute myocardial infarction
|
|
ES2232287B1
(es)
*
|
2003-07-04 |
2006-11-01 |
Advanced In Vitro Cell Technologies, S.L. |
Nanoparticulas de derivados polioxietilenados.
|
|
US7326571B2
(en)
|
2003-07-17 |
2008-02-05 |
Boston Scientific Scimed, Inc. |
Decellularized bone marrow extracellular matrix
|
|
EP2272566A3
(de)
|
2003-08-18 |
2013-01-02 |
MedImmune, LLC |
Humanisierung von antikörpern
|
|
US7371381B2
(en)
|
2003-12-12 |
2008-05-13 |
Amgen Inc. |
Anti-galanin antibodies and uses thereof
|
|
MXPA06006738A
(es)
|
2003-12-19 |
2006-08-31 |
Univ North Carolina |
Metodos para fabricar micro- y nano-estructuras aisladas utilizando litografia suave o de impresion.
|
|
US9040090B2
(en)
|
2003-12-19 |
2015-05-26 |
The University Of North Carolina At Chapel Hill |
Isolated and fixed micro and nano structures and methods thereof
|
|
US20070259047A1
(en)
*
|
2004-02-26 |
2007-11-08 |
Yasuaki Ogawa |
Protein Sustained-Release Microparticle Preparation for Injection and Process for Producing the Same
|
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
|
WO2006080951A2
(en)
*
|
2004-07-01 |
2006-08-03 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
WO2006012394A1
(en)
|
2004-07-21 |
2006-02-02 |
Tulane University Health Sciences Center |
Treatment of renal dysfunction and multiple myeloma using pacap compounds
|
|
CA2585717A1
(en)
|
2004-10-27 |
2006-05-04 |
Medimmune Inc. |
Modulation of antibody specificity by tailoring the affinity to cognate antigens
|
|
CA2586035A1
(en)
|
2004-11-01 |
2006-05-11 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
|
|
EP1812056B1
(de)
|
2004-11-15 |
2013-08-07 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogene zusammensetzungen, welche ein anthrax antigen, mikropartikel aus biologisch abbaubaren polymeren, und ein nukleinsäurehältiges adjuvans beinhalten.
|
|
CA2600085A1
(en)
*
|
2005-03-09 |
2006-09-14 |
Toray Industries, Inc. |
Microparticle and pharmaceutical preparation
|
|
CA2602035C
(en)
|
2005-03-18 |
2015-06-16 |
Medimmune, Inc. |
Framework-shuffling of antibodies
|
|
ES2971647T3
(es)
|
2005-04-15 |
2024-06-06 |
Macrogenics Inc |
Diacuerpos covalentes y usos de los mismos
|
|
EP1888510A4
(de)
*
|
2005-05-27 |
2013-01-16 |
Univ North Carolina |
Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen
|
|
KR20080025174A
(ko)
|
2005-06-23 |
2008-03-19 |
메디뮨 인코포레이티드 |
응집 및 단편화 프로파일이 최적화된 항체 제제
|
|
WO2007011707A2
(en)
|
2005-07-15 |
2007-01-25 |
Micell Technologies, Inc. |
Polymer coatings containing drug powder of controlled morphology
|
|
WO2007011708A2
(en)
|
2005-07-15 |
2007-01-25 |
Micell Technologies, Inc. |
Stent with polymer coating containing amorphous rapamycin
|
|
PL2573114T3
(pl)
|
2005-08-10 |
2016-10-31 |
|
Identyfikacja i inżynieria przeciwciał z wariantami regionów FC oraz sposoby ich stosowania
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
EP2500355A3
(de)
|
2005-08-19 |
2012-10-24 |
Abbott Laboratories |
Immunglobuline mit zweifacher variabler Domäne und ihre Verwendung
|
|
NZ612578A
(en)
|
2005-08-19 |
2014-11-28 |
Abbvie Inc |
Dual variable domain immunoglobin and uses thereof
|
|
TWI388344B
(zh)
*
|
2005-08-23 |
2013-03-11 |
Celsion Corp |
儲存奈米微粒調合物之方法
|
|
EP1928905B1
(de)
|
2005-09-30 |
2015-04-15 |
AbbVie Deutschland GmbH & Co KG |
Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
|
|
US8691224B2
(en)
|
2005-11-30 |
2014-04-08 |
Abbvie Inc. |
Anti-Aβ globulomer 5F7 antibodies
|
|
HRP20140240T4
(hr)
|
2005-11-30 |
2017-02-24 |
Abbvie Inc. |
Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba
|
|
CA2631714C
(en)
|
2005-12-02 |
2014-09-16 |
Novartis Ag |
Nanoparticles for use in immunogenic compositions
|
|
WO2007074604A1
(ja)
|
2005-12-26 |
2007-07-05 |
Ltt Bio-Pharma Co., Ltd. |
水溶性非ペプチド性低分子薬物含有ナノ粒子
|
|
US20070166800A1
(en)
*
|
2006-01-13 |
2007-07-19 |
Haixiang Lin |
Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
|
|
EP2012751A4
(de)
|
2006-03-21 |
2010-11-24 |
Morehouse School Of Medicine |
Neue nanopartikel zur wirkstofffreisetzung
|
|
ES2540059T3
(es)
|
2006-04-26 |
2015-07-08 |
Micell Technologies, Inc. |
Recubrimientos que contienen múltiples fármacos
|
|
SG177907A1
(en)
|
2006-06-14 |
2012-02-28 |
Macrogenics Inc |
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
|
|
ES2599319T3
(es)
|
2006-06-26 |
2017-02-01 |
Macrogenics, Inc. |
Anticuerpos específicos de Fc RIIB y métodos de uso de éstos
|
|
AU2007290570C1
(en)
|
2006-08-28 |
2013-08-15 |
Kyowa Kirin Co., Ltd. |
Antagonistic human LIGHT-specific human monoclonal antibodies
|
|
JP2010502224A
(ja)
|
2006-09-08 |
2010-01-28 |
アボット・ラボラトリーズ |
インターロイキン１３結合タンパク質
|
|
EP2061583B1
(de)
*
|
2006-09-14 |
2019-04-10 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Organische nanopartikel, erhalten aus mikroemulsionen durch lösungsmittelverdampfung
|
|
AU2007313300A1
(en)
|
2006-10-16 |
2008-04-24 |
Medimmune, Llc. |
Molecules with reduced half-lives, compositions and uses thereof
|
|
US8529959B2
(en)
|
2006-10-17 |
2013-09-10 |
Carmell Therapeutics Corporation |
Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
|
|
CA2667228C
(en)
|
2006-10-23 |
2015-07-14 |
Micell Technologies, Inc. |
Holder for electrically charging a substrate during coating
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
CA2679712C
(en)
|
2007-01-08 |
2016-11-15 |
Micell Technologies, Inc. |
Stents having biodegradable layers
|
|
US11426494B2
(en)
|
2007-01-08 |
2022-08-30 |
MT Acquisition Holdings LLC |
Stents having biodegradable layers
|
|
US20080175874A1
(en)
*
|
2007-01-19 |
2008-07-24 |
The Procter & Gamble Company |
Applied care compositions comprising functionalized nano-particles
|
|
DE102007005191A1
(de)
|
2007-01-29 |
2008-07-31 |
Rüdiger Marcus Dr. Dr. Flaig |
Verbessertes Ktenat zum Arzneimitteltransport
|
|
DE102007005190A1
(de)
|
2007-01-29 |
2008-07-31 |
Flaig, Rüdiger Marcus, Dr. Dr. |
Selektive Kontaktcytotoxika
|
|
JP4621218B2
(ja)
*
|
2007-02-09 |
2011-01-26 |
有限会社バイオ研 |
Ｔｈ１誘導剤及びその製造方法
|
|
US10265407B2
(en)
|
2007-02-15 |
2019-04-23 |
Yale University |
Modular nanodevices for smart adaptable vaccines
|
|
AU2008219065B2
(en)
|
2007-02-19 |
2014-01-30 |
Marine Polymer Technologies, Inc. |
Hemostatic compositions and therapeutic regimens
|
|
US8895004B2
(en)
|
2007-02-27 |
2014-11-25 |
AbbVie Deutschland GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
US20100303901A1
(en)
*
|
2007-04-26 |
2010-12-02 |
Eyal Shimoni |
Oral delivery of proteins and peptides
|
|
AU2008256684B2
(en)
|
2007-05-25 |
2012-06-14 |
Micell Technologies, Inc. |
Polymer films for medical device coating
|
|
EP1997830A1
(de)
|
2007-06-01 |
2008-12-03 |
AIMM Therapeutics B.V. |
RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
|
|
EP2158221B1
(de)
|
2007-06-21 |
2018-08-29 |
MacroGenics, Inc. |
Kovalente diabodies und deren verwendung
|
|
KR20100058509A
(ko)
|
2007-07-31 |
2010-06-03 |
메디뮨 엘엘씨 |
다중특이적 에피토프 결합 단백질 및 이의 용도
|
|
CN101868180A
(zh)
|
2007-10-09 |
2010-10-20 |
圣路易斯华盛顿州立大学 |
成像粒子
|
|
US9468607B2
(en)
|
2007-10-09 |
2016-10-18 |
Washington University |
Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
|
|
DE102007054049A1
(de)
|
2007-11-13 |
2009-05-14 |
Flaig, Rüdiger Marcus, Dr. Dr. |
Arzneimitteltransportsystem zur Bekämpfung von Trypanosomen
|
|
KR100961880B1
(ko)
*
|
2007-12-12 |
2010-06-09 |
중앙대학교 산학협력단 |
밀링에 의한 기능성 약물나노입자의 제조방법 및 상기제조방법에 의해 입자 표면이 개질된 약물나노입자 제제
|
|
BRPI0907046A2
(pt)
|
2008-01-18 |
2015-07-28 |
Medimmune Llc |
Anticorpo de cisteína engenheirada, ácido nucleico isolado, vetor, célula hospedeira, conjugado de anticorpo, composição farmacêutica, métodos de detecção de câncer, doenças ou distúrbios autoimunes, inflamatórios ou infecciosos em um indivíduo e de inibição de proliferação de uma célula alvo
|
|
EP2251006B1
(de)
|
2008-02-22 |
2017-07-19 |
Toray Industries, Inc. |
Mikropartikel und pharmazeutische zusammensetzungen daraus
|
|
WO2009105760A2
(en)
*
|
2008-02-22 |
2009-08-27 |
Musculoskeletal Transplant Foundation |
Biologic matrices comprising anti-infective, methods and compositions related thereto
|
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
|
CN102083397B
(zh)
|
2008-04-17 |
2013-12-25 |
米歇尔技术公司 |
具有生物可吸收层的支架
|
|
EP2282771B1
(de)
|
2008-04-28 |
2014-06-25 |
Novartis AG |
Verfahren zur herstellung von nanoteilchen
|
|
SG190572A1
(en)
|
2008-04-29 |
2013-06-28 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
KR101005562B1
(ko)
|
2008-05-01 |
2011-01-05 |
한국생명공학연구원 |
난용성 약물을 함유하는 균일한 크기의 고분자 나노입자제조방법
|
|
EP2116556B1
(de)
|
2008-05-09 |
2016-03-23 |
AbbVie Deutschland GmbH & Co KG |
Antikörper zu Rezeptor für Endprodukte der fortgeschrittenen Glykierung (RAGE) und Verwendungen davon
|
|
TW201006485A
(en)
|
2008-06-03 |
2010-02-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
CA2726087A1
(en)
|
2008-06-03 |
2009-12-10 |
Tariq Ghayur |
Dual variable domain immunoglobulins and uses thereof
|
|
EA020954B1
(ru)
|
2008-06-16 |
2015-03-31 |
Бинд Терапьютикс, Инк. |
Загруженные лекарственным средством полимерные наночастицы, фармацевтическая композиция и способ лечения рака
|
|
US8318211B2
(en)
|
2008-06-16 |
2012-11-27 |
Bind Biosciences, Inc. |
Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
|
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
|
TW201014602A
(en)
|
2008-07-08 |
2010-04-16 |
Abbott Lab |
Prostaglandin E2 binding proteins and uses thereof
|
|
CN102149825B
(zh)
|
2008-07-08 |
2015-07-22 |
Abbvie公司 |
前列腺素e2双重可变结构域免疫球蛋白及其用途
|
|
JP2011528275A
(ja)
|
2008-07-17 |
2011-11-17 |
ミセル テクノロジーズ，インク． |
薬物送達医療デバイス
|
|
US20110256059A1
(en)
|
2008-10-28 |
2011-10-20 |
Universidade De Santiago De Compostela |
Nanoparticulate systems prepared from anionic polymers
|
|
US8563041B2
(en)
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
|
JP2012512175A
(ja)
|
2008-12-15 |
2012-05-31 |
バインド バイオサイエンシズ インコーポレイテッド |
治療薬を徐放するための長時間循環性ナノ粒子
|
|
DK2786762T3
(da)
|
2008-12-19 |
2019-05-06 |
Macrogenics Inc |
Kovalente diabodies og anvendelser deraf
|
|
US8834913B2
(en)
|
2008-12-26 |
2014-09-16 |
Battelle Memorial Institute |
Medical implants and methods of making medical implants
|
|
US8030026B2
(en)
|
2009-02-24 |
2011-10-04 |
Abbott Laboratories |
Antibodies to troponin I and methods of use thereof
|
|
TWI541021B
(zh)
|
2009-03-05 |
2016-07-11 |
艾伯維有限公司 |
Ｉｌ－１７結合蛋白
|
|
US8283162B2
(en)
|
2009-03-10 |
2012-10-09 |
Abbott Laboratories |
Antibodies relating to PIVKAII and uses thereof
|
|
WO2010120552A2
(en)
|
2009-04-01 |
2010-10-21 |
Micell Technologies, Inc. |
Coated stents
|
|
EP3366326A1
(de)
|
2009-04-17 |
2018-08-29 |
Micell Technologies, Inc. |
Stents mit gesteuerter elution
|
|
BRPI1012036A2
(pt)
|
2009-05-27 |
2017-10-10 |
Selecta Biosciences Inc |
nanocarreadores que possuem componentes com diferentes taxas de liberação
|
|
EP2437767B1
(de)
|
2009-06-01 |
2015-07-08 |
MedImmune, LLC |
Moleküle mit verlängerter halbwertzeit und verwendungen dafür
|
|
EP2711018A1
(de)
|
2009-06-22 |
2014-03-26 |
MedImmune, LLC |
Manipulierte Fc-Regionen für standortspezifische Konjugation
|
|
EP2453834A4
(de)
|
2009-07-16 |
2014-04-16 |
Micell Technologies Inc |
Medizinische wirkstofffreisetzungsvorrichtung
|
|
BR112012003804B1
(pt)
|
2009-08-21 |
2019-02-19 |
Novan, Inc. |
Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
|
|
WO2011022652A1
(en)
|
2009-08-21 |
2011-02-24 |
Novan, Inc. |
Topical gels
|
|
BR112012004546A8
(pt)
|
2009-08-29 |
2017-12-05 |
Abbott Lab |
Terapêutica por proteínas ligantes dll4-ligantes
|
|
WO2011028811A2
(en)
|
2009-09-01 |
2011-03-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
|
US20120177741A1
(en)
*
|
2009-09-29 |
2012-07-12 |
Eyegate Pharmaceuticals, Inc. |
Positively-charged poly (d,l-lactide-co-glycolide) nanoparticles and fabrication methods of the same
|
|
US8568726B2
(en)
|
2009-10-06 |
2013-10-29 |
Medimmune Limited |
RSV specific binding molecule
|
|
JP5898082B2
(ja)
|
2009-10-07 |
2016-04-06 |
マクロジェニクス，インコーポレーテッド |
フコシル化程度の変更により改良されたエフェクター機能を示すＦｃ領域含有ポリペプチドおよびその使用法
|
|
BR112012008833A2
(pt)
|
2009-10-15 |
2015-09-08 |
Abbott Lab |
imunoglobulinas de dominio variavel duplo e usos das mesmas
|
|
US10034829B2
(en)
|
2010-10-27 |
2018-07-31 |
Noxell Corporation |
Semi-permanent mascara compositions
|
|
US9237992B2
(en)
|
2009-10-27 |
2016-01-19 |
The Procter & Gamble Company |
Two-step mascara product
|
|
US9216145B2
(en)
|
2009-10-27 |
2015-12-22 |
The Procter & Gamble Company |
Semi-permanent cosmetic concealer
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
WO2011053707A1
(en)
|
2009-10-31 |
2011-05-05 |
Abbott Laboratories |
Antibodies to receptor for advanced glycation end products (rage) and uses thereof
|
|
CA2779496A1
(en)
|
2009-11-02 |
2011-05-05 |
The Administrators Of The Tulane Educational Fund |
Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use
|
|
MX2012006560A
(es)
|
2009-12-08 |
2012-10-05 |
Abbott Gmbh & Co Kg |
Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal.
|
|
DK2509634T3
(en)
|
2009-12-11 |
2019-04-23 |
Pfizer |
Stable formulations for lyophilization of therapeutic particles
|
|
EP2515942B1
(de)
|
2009-12-15 |
2020-02-12 |
Pfizer Inc. |
Therapeutische polymernanopartikelzusammensetzungen mit hoher glasübergangstemperatur oder copolymeren von hohem molekulargewicht
|
|
US9764043B2
(en)
|
2009-12-17 |
2017-09-19 |
Washington University |
Antithrombotic nanoparticle
|
|
US9808500B2
(en)
|
2009-12-17 |
2017-11-07 |
Washington University |
Antithrombotic nanoparticle
|
|
EP2531140B1
(de)
|
2010-02-02 |
2017-11-01 |
Micell Technologies, Inc. |
Stent und stenteinsatzsystem mit verbesserter einsetzbarkeit
|
|
WO2011105520A1
(ja)
|
2010-02-26 |
2011-09-01 |
国立大学法人 長崎大学 |
抗原または薬物送達複合体
|
|
KR101853278B1
(ko)
|
2010-03-02 |
2018-05-02 |
애브비 인코포레이티드 |
치료학적 ｄｌｌ４ 결합 단백질
|
|
US8795762B2
(en)
|
2010-03-26 |
2014-08-05 |
Battelle Memorial Institute |
System and method for enhanced electrostatic deposition and surface coatings
|
|
US8987419B2
(en)
|
2010-04-15 |
2015-03-24 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
|
CN103096874A
(zh)
|
2010-04-15 |
2013-05-08 |
华盛顿大学 |
前药组合物、前药纳米粒子及其使用方法
|
|
EP2560576B1
(de)
|
2010-04-22 |
2018-07-18 |
Micell Technologies, Inc. |
Stents und andere vorrichtungen mit beschichtung durch eine extrazelluläre matrix
|
|
US9004791B2
(en)
|
2010-04-30 |
2015-04-14 |
The Procter & Gamble Company |
Package for multiple personal care compositions
|
|
PH12012502193A1
(en)
|
2010-05-06 |
2021-08-09 |
Novartis Ag |
Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
|
|
EP2566892B1
(de)
|
2010-05-06 |
2017-12-20 |
Novartis AG |
Zusammensetzungen und verfahren zur verwendung von therapeutischen antikörpern gegen ldl-assoziiertes protein 6 (lrp6)
|
|
AR081246A1
(es)
|
2010-05-14 |
2012-07-18 |
Abbott Lab |
Proteinas de union a il-1
|
|
CA2798739A1
(en)
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Nanocarrier compositions with uncoupled adjuvant
|
|
US20110318421A1
(en)
*
|
2010-06-24 |
2011-12-29 |
Edward E. Parsonage |
Surface functionalized ceramic nanoparticles
|
|
WO2012006500A2
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
WO2012009684A2
(en)
|
2010-07-16 |
2012-01-19 |
Micell Technologies, Inc. |
Drug delivery medical device
|
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
|
AU2011286024B2
(en)
|
2010-08-02 |
2014-08-07 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
EP3252072A3
(de)
|
2010-08-03 |
2018-03-14 |
AbbVie Inc. |
Immunglobuline mit zweifacher variabler domäne und verwendungen davon
|
|
EP3533803B1
(de)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antikörper
|
|
WO2012024650A2
(en)
|
2010-08-19 |
2012-02-23 |
Abbott Laboratories |
Anti-ngf antibodies and their use
|
|
AU2011290672B2
(en)
|
2010-08-20 |
2015-07-09 |
Novartis Ag |
Antibodies for epidermal growth factor receptor 3 (HER3)
|
|
JP2013539364A
(ja)
|
2010-08-26 |
2013-10-24 |
アッヴィ・インコーポレイテッド |
二重可変ドメイン免疫グロブリンおよびその使用
|
|
PT3213738T
(pt)
|
2010-08-27 |
2020-03-31 |
Sebacia Inc |
Composições e métodos para modulação térmica direcionada
|
|
US9572880B2
(en)
|
2010-08-27 |
2017-02-21 |
Sienna Biopharmaceuticals, Inc. |
Ultrasound delivery of nanoparticles
|
|
WO2012069466A1
(en)
|
2010-11-24 |
2012-05-31 |
Novartis Ag |
Multispecific molecules
|
|
US8591876B2
(en)
|
2010-12-15 |
2013-11-26 |
Novan, Inc. |
Methods of decreasing sebum production in the skin
|
|
TW201307388A
(zh)
|
2010-12-21 |
2013-02-16 |
Abbott Lab |
Ｉｌ－１結合蛋白
|
|
PE20141060A1
(es)
|
2010-12-21 |
2014-09-26 |
Abbvie Inc |
Inmunoglobulinas de dominio variable dual biespecificas de il-1 alfa y beta y su uso
|
|
WO2012092504A2
(en)
*
|
2010-12-30 |
2012-07-05 |
Micell Technologies, Inc. |
Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore
|
|
JP6082901B2
(ja)
*
|
2011-01-31 |
2017-02-22 |
オリンパス株式会社 |
ワクチン・アジュバント
|
|
ES2695173T3
(es)
|
2011-02-28 |
2019-01-02 |
Novan Inc |
Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
|
|
JP6072771B2
(ja)
|
2011-04-20 |
2017-02-01 |
メディミューン，エルエルシー |
Ｂ７−ｈ１およびｐｄ−１に結合する抗体およびその他の分子
|
|
MX374963B
(es)
|
2011-04-29 |
2025-03-06 |
Selecta Biosciences Inc |
Nanoportadores sintéticos tolerogénicos para reducir las respuestas de anticuerpos.
|
|
US9173824B2
(en)
|
2011-05-17 |
2015-11-03 |
The Procter & Gamble Company |
Mascara and applicator
|
|
BR112013029892A2
(pt)
|
2011-05-21 |
2016-12-20 |
Macrogenics Inc |
polipeptídeo, molécula de ligação a antígeno, diacorpo e uso de uma porção polipeptídica de uma proteína de ligação a soro desimunizada
|
|
WO2012166819A1
(en)
|
2011-05-31 |
2012-12-06 |
Micell Technologies, Inc. |
System and process for formation of a time-released, drug-eluting transferable coating
|
|
SG10201505454SA
(en)
|
2011-07-13 |
2015-09-29 |
Abbvie Inc |
Methods and compositions for treating asthma using anti-il-13 antibodies
|
|
CA2841360A1
(en)
|
2011-07-15 |
2013-01-24 |
Micell Technologies, Inc. |
Drug delivery medical device
|
|
KR20140050698A
(ko)
|
2011-07-29 |
2014-04-29 |
셀렉타 바이오사이언시즈, 인크. |
체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
|
|
US9676854B2
(en)
|
2011-08-15 |
2017-06-13 |
Medimmune, Llc |
Anti-B7-H4 antibodies and their uses
|
|
EP2758434A2
(de)
|
2011-09-23 |
2014-07-30 |
Technophage, Investigação E Desenvolvimento Em Biotecnologia, SA |
Antitumornekrosefaktor-alpha-wirkstoffe und ihre verwendung
|
|
US10188772B2
(en)
|
2011-10-18 |
2019-01-29 |
Micell Technologies, Inc. |
Drug delivery medical device
|
|
AU2012326010B2
(en)
*
|
2011-10-18 |
2017-05-11 |
Micell Technologies, Inc. |
Drug delivery medical device
|
|
HK1200322A1
(en)
|
2011-10-24 |
2015-08-07 |
Abbvie Inc. |
Immunobinders directed against sclerostin
|
|
EP3590538A1
(de)
|
2011-12-05 |
2020-01-08 |
Novartis AG |
Antikörper für den epidermalen wachstumsfaktorrezeptor 3 (her 3)
|
|
CN104105709A
(zh)
|
2011-12-05 |
2014-10-15 |
诺华股份有限公司 |
抗her3的结构域ii的表皮生长因子受体3(her3)抗体
|
|
CA2855570A1
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
|
CA3204283A1
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
|
JP2015502397A
(ja)
|
2011-12-23 |
2015-01-22 |
ファイザー・インク |
部位特異的コンジュゲーションのための操作された抗体定常領域、ならびにそのための方法および使用
|
|
TW201333035A
(zh)
|
2011-12-30 |
2013-08-16 |
Abbvie Inc |
針對ｉｌ－１３及／或ｉｌ－１７之雙特異性結合蛋白
|
|
EP3369746A1
(de)
|
2012-01-27 |
2018-09-05 |
AbbVie Deutschland GmbH & Co KG |
Zusammensetzung und verfahren zur diagnose und behandlung von krankheiten im zusammenhang mit neuritenabbau
|
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
|
WO2013137498A1
(ko)
*
|
2012-03-14 |
2013-09-19 |
인제대학교 산학협력단 |
천연 수용성 고분자로 표면 개질된 생분해성 합성 고분자를 포함하는 조직 재생용 칩의 제조 방법 및 이에 의하여 제조된 조직 재생용 칩
|
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
|
US9140681B2
(en)
|
2012-05-15 |
2015-09-22 |
The Procter & Gamble Company |
Method for quantitatively determining eyelash clumping
|
|
EP2855520B1
(de)
|
2012-06-04 |
2018-09-26 |
Novartis AG |
Verfahren zur stellenspezifischen markierung und dadurch hergestellte moleküle
|
|
CA2875783C
(en)
|
2012-06-06 |
2018-12-11 |
Zoetis Llc |
Caninized anti-ngf antibodies and methods thereof
|
|
US20140148671A1
(en)
*
|
2012-07-05 |
2014-05-29 |
Empire Technology Development Llc |
Compositions and methods for detecting anastomosis leakage
|
|
UY34905A
(es)
|
2012-07-12 |
2014-01-31 |
Abbvie Inc |
Proteínas de unión a il-1
|
|
WO2014043618A1
(en)
|
2012-09-17 |
2014-03-20 |
Bind Therapeutics, Inc. |
Process for preparing therapeutic nanoparticles
|
|
AU2013329450B2
(en)
*
|
2012-10-11 |
2017-06-22 |
Coronado Aesthetics, Llc |
Silver nanoplate compositions and methods
|
|
TW202037609A
(zh)
|
2012-11-01 |
2020-10-16 |
美商艾伯維有限公司 |
抗-vegf/dll4雙重可變區域免疫球蛋白及其用途
|
|
CA2890483A1
(en)
|
2012-11-09 |
2014-05-15 |
Robert ARCH |
Platelet-derived growth factor b specific antibodies and compositions and uses thereof
|
|
CA2894879A1
(en)
|
2012-12-19 |
2014-06-26 |
Amplimmune, Inc. |
B7-h4 specific antibodies, and compositions and methods of use thereof
|
|
BR112015014621A2
(pt)
|
2012-12-21 |
2017-10-03 |
Amplimmune Inc |
Anticorpos anti-h7cr
|
|
WO2014124258A2
(en)
|
2013-02-08 |
2014-08-14 |
Irm Llc |
Specific sites for modifying antibodies to make immunoconjugates
|
|
EP2953976B1
(de)
|
2013-02-08 |
2021-03-24 |
Novartis Ag |
Spezifische stellen zur modifizierung von antikörper zur herstellung von immunkonjugaten
|
|
KR20150143476A
(ko)
|
2013-03-12 |
2015-12-23 |
미셀 테크놀로지즈, 인코포레이티드 |
생흡수성 생체의학적 임플란트
|
|
US9498532B2
(en)
|
2013-03-13 |
2016-11-22 |
Novartis Ag |
Antibody drug conjugates
|
|
MX362075B
(es)
|
2013-03-14 |
2019-01-07 |
Abbott Lab |
Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
|
|
JP2016512241A
(ja)
|
2013-03-14 |
2016-04-25 |
アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ |
改良された抗体検出のためのｈｃｖｎｓ３組換え抗原およびこの突然変異体
|
|
WO2014143343A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbott Laboratories |
Hcv core lipid binding domain monoclonal antibodies
|
|
EP3611189A1
(de)
|
2013-03-14 |
2020-02-19 |
Novartis AG |
Antikörper gegen notch 3
|
|
US9993427B2
(en)
|
2013-03-14 |
2018-06-12 |
Biorest Ltd. |
Liposome formulation and manufacture
|
|
WO2014144280A2
(en)
|
2013-03-15 |
2014-09-18 |
Abbvie Inc. |
DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1β AND / OR IL-17
|
|
ES2701051T3
(es)
|
2013-03-15 |
2019-02-20 |
Novartis Ag |
Conjugados de anticuerpo-fármaco
|
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
|
KR102233251B1
(ko)
|
2013-04-03 |
2021-03-26 |
엔-폴드 엘엘씨 |
신규 나노입자 조성물
|
|
BR122020023215B1
(pt)
|
2013-05-03 |
2022-11-22 |
Selecta Biosciences, Inc |
Composição e kit de nanocarreadores sintéticos tolerogênicos para reduzir ou prevenir anafilaxia em resposta a um antígeno não alergênico
|
|
HK1222313A1
(zh)
|
2013-05-15 |
2017-06-30 |
Micell Technologies, Inc. |
可生物吸收的生物医学植入物
|
|
BR112015029395A2
(pt)
|
2013-05-24 |
2017-09-19 |
Medimmune Llc |
Anticorpos anti-b7-h5 e seus usos
|
|
SG11201509982UA
(de)
|
2013-06-06 |
2016-04-28 |
Igenica Biotherapeutics Inc |
|
|
US10183988B2
(en)
|
2013-06-07 |
2019-01-22 |
Duke University |
Anti-Complement factor H antibodies
|
|
UA116479C2
(uk)
|
2013-08-09 |
2018-03-26 |
Макродженікс, Інк. |
БІСПЕЦИФІЧНЕ МОНОВАЛЕНТНЕ Fc-ДІАТІЛО, ЯКЕ ОДНОЧАСНО ЗВ'ЯЗУЄ CD32B I CD79b, ТА ЙОГО ЗАСТОСУВАННЯ
|
|
US11384149B2
(en)
|
2013-08-09 |
2022-07-12 |
Macrogenics, Inc. |
Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof
|
|
EP2840091A1
(de)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bispezifische Diabodies, die gpA33 und CD3 binden können und Anwendungen dieser
|
|
EP2839842A1
(de)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bispezifische monovalente Diabodies mit Fähigkeit zur Bindung von CD123 und CD3 und Verwendungen davon
|
|
RS60093B1
(sr)
|
2013-09-16 |
2020-05-29 |
Astrazeneca Ab |
Terapeutske polimerne nanočestice i postupci njihove pripreme i primene
|
|
CA2923772A1
(en)
|
2013-09-17 |
2015-03-26 |
University Health Network (Uhn): Technology Development And Commercialization |
Agents directed against a cis rgma/neogenin interaction or lipid rafts and use of the same in methods of treatment
|
|
WO2015058868A1
(en)
|
2013-10-25 |
2015-04-30 |
Pangaea Biotech, S.L. |
Compositions and methods for the treatment of cancer
|
|
US9683998B2
(en)
|
2013-11-13 |
2017-06-20 |
Pfizer Inc. |
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
|
|
CA2931978A1
(en)
|
2013-12-02 |
2015-06-11 |
Abbvie Inc. |
Compositions and methods for treating osteoarthritis
|
|
WO2015109212A1
(en)
|
2014-01-17 |
2015-07-23 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
|
PE20170256A1
(es)
|
2014-01-24 |
2017-04-22 |
Ngm Biopharmaceuticals Inc |
Proteinas de union y sus metodos de uso
|
|
KR20160135190A
(ko)
|
2014-02-14 |
2016-11-25 |
앤드류 에스. 카이 |
혈관형성 암의 치료를 위한 개선된 방법
|
|
US10272117B2
(en)
|
2014-02-24 |
2019-04-30 |
Celgene Corporation |
Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
|
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
|
US20150291689A1
(en)
|
2014-03-09 |
2015-10-15 |
Abbvie, Inc. |
Compositions and Methods for Treating Rheumatoid Arthritis
|
|
JP2017509337A
(ja)
|
2014-03-12 |
2017-04-06 |
ノバルティス アーゲー |
イムノコンジュゲートを作製する抗体を修飾するための特定部位
|
|
PE20170312A1
(es)
|
2014-03-14 |
2017-03-30 |
Pfizer |
Nanoparticulas terapeuticas que comprenden un agente terapeutico, y metodos para su elaboracion y uso
|
|
AR099812A1
(es)
|
2014-03-21 |
2016-08-17 |
Abbvie Inc |
Anticuerpos y conjugados de anticuerpo y fármaco anti-egfr
|
|
ES2869459T3
(es)
|
2014-05-16 |
2021-10-25 |
Medimmune Llc |
Moléculas con unión a receptor de fc de neonato alterada que tiene propiedades terapéuticas y de diagnóstico potenciadas
|
|
US20170105407A1
(en)
*
|
2014-05-21 |
2017-04-20 |
Albert Einstein College Of Medicine, Inc. |
Compositions and methods for enhancing red blood cell storage time and survivability using nitric oxide releasing hybrid hydrogel nanoparticles
|
|
EA035419B9
(ru)
|
2014-05-29 |
2020-08-07 |
Мэкроудженикс, Инк. |
Триспецифичные связывающие молекулы и способы их применения
|
|
TWI693232B
(zh)
|
2014-06-26 |
2020-05-11 |
美商宏觀基因股份有限公司 |
與pd-1和lag-3具有免疫反應性的共價結合的雙抗體和其使用方法
|
|
EP3539990B1
(de)
|
2014-07-16 |
2021-09-08 |
Dana-Farber Cancer Institute, Inc. |
Her3-inhibition bei serösem low-grade ovarialkarzinom
|
|
WO2016020791A1
(en)
|
2014-08-05 |
2016-02-11 |
Novartis Ag |
Ckit antibody drug conjugates
|
|
MA40513A
(fr)
|
2014-08-12 |
2017-06-21 |
Novartis Ag |
Conjugués médicament-anticorps anti-cdh6
|
|
JP7242180B2
(ja)
|
2014-09-07 |
2023-03-20 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
抗ウイルス導入ベクター免疫応答を減弱化するための方法および組成物
|
|
MX375669B
(es)
|
2014-09-26 |
2025-03-06 |
Macrogenics Inc |
Diacuerpos monovalentes biespecificos que son capaces de unir cd19 y cd3, y usos de los mismos.
|
|
TW201625692A
(zh)
|
2014-11-14 |
2016-07-16 |
諾華公司 |
抗體藥物結合物
|
|
US10093733B2
(en)
|
2014-12-11 |
2018-10-09 |
Abbvie Inc. |
LRP-8 binding dual variable domain immunoglobulin proteins
|
|
JP6800853B2
(ja)
|
2014-12-11 |
2020-12-16 |
ピエール、ファーブル、メディカマン |
抗ｃ１０ｏｒｆ５４抗体およびその使用
|
|
JP6847848B2
(ja)
|
2014-12-15 |
2021-03-24 |
ザ ジョーンズ ホプキンズ ユニバーシティＴｈｅ Ｊｏｈｎｓ Ｈｏｐｋｉｎｓ Ｕｎｉｖｅｒｓｉｔｙ |
スニチニブ製剤、及び緑内障の治療におけるその使用方法
|
|
TW201639596A
(zh)
|
2015-01-24 |
2016-11-16 |
艾伯維有限公司 |
用於治療牛皮癬性關節炎之組合物及方法
|
|
RU2017129236A
(ru)
|
2015-01-26 |
2019-03-07 |
Макродженикс, Инк. |
Мультивалентные молекулы, содержащие dr5-связывающие домены
|
|
KR20250005465A
(ko)
|
2015-03-03 |
2025-01-09 |
키맵 리미티드 |
항체, 용도 및 방법
|
|
CN107810198B
(zh)
|
2015-05-29 |
2021-09-03 |
艾伯维公司 |
抗cd40抗体及其用途
|
|
TWI773646B
(zh)
|
2015-06-08 |
2022-08-11 |
美商宏觀基因股份有限公司 |
結合lag-3的分子和其使用方法
|
|
US10322169B2
(en)
*
|
2015-06-10 |
2019-06-18 |
Evonik Roehm Gmbh |
Process for preparing a powder comprising a human coagulation factor protein and a lactic acid polymer
|
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白
|
|
US20190194315A1
(en)
|
2015-06-17 |
2019-06-27 |
Novartis Ag |
Antibody drug conjugates
|
|
WO2016205010A1
(en)
*
|
2015-06-19 |
2016-12-22 |
The Regents Of The University Of California |
Treating vasculature related diseases or disorders using nanoparticles
|
|
US11066481B2
(en)
|
2015-07-23 |
2021-07-20 |
The Regents Of The University Of California |
Antibodies to coagulation factor XIa and uses thereof
|
|
HUE068868T2
(hu)
|
2015-07-30 |
2025-02-28 |
Macrogenics Inc |
PD-1-hez kötõdõ molekulák és alkalmazásukra szolgáló eljárások
|
|
KR101709628B1
(ko)
*
|
2015-09-10 |
2017-02-24 |
한국과학기술연구원 |
개질된 생분해성 고분자의 제조 방법, 그에 의해 제조된 개질된 생분해성 고분자 및 이를 이용한 생분해성 스텐트
|
|
JP2018526404A
(ja)
|
2015-09-11 |
2018-09-13 |
アッヴィ・インコーポレイテッド |
再発型の多発性硬化症を治療するための方法
|
|
US9862760B2
(en)
|
2015-09-16 |
2018-01-09 |
Novartis Ag |
Polyomavirus neutralizing antibodies
|
|
BR112018006237A2
(pt)
|
2015-09-29 |
2018-10-09 |
Celgene Corp |
proteínas de ligação a pd-1 e métodos de uso das mesmas
|
|
WO2017070578A1
(en)
|
2015-10-21 |
2017-04-27 |
The Regents Of The University Of Michigan |
Detection and treatment of caries and microcavities with nanoparticles
|
|
CN115636880A
(zh)
|
2015-10-23 |
2023-01-24 |
辉瑞有限公司 |
抗il-2抗体及其组合物和用途
|
|
HK1257499A1
(zh)
*
|
2015-11-12 |
2019-10-25 |
Graybug Vision, Inc. |
用於治疗的聚集性微粒
|
|
EP3383908A1
(de)
|
2015-12-02 |
2018-10-10 |
Stsciences, Inc. |
Spezifische antikörper gegen glykosylierten btla (b- und t-lymphozyt-attenuator)
|
|
EP3383911B1
(de)
|
2015-12-02 |
2021-01-20 |
STCube & Co. Inc. |
Antikörper und moleküle die immunspezifisch an btn1a1 binden und therapeutische verwendungen davon
|
|
IL260021B
(en)
|
2015-12-14 |
2022-09-01 |
Macrogenics Inc |
Bispecific molecules that are immunoreactive for pd1 and ctla4 and methods for using them
|
|
MA55746A
(fr)
|
2016-01-21 |
2022-03-02 |
Novartis Ag |
Molécules multispécifiques ciblant cll-1
|
|
US11298678B2
(en)
|
2016-03-30 |
2022-04-12 |
Trustees Of Tufts College |
Fabrication of macroporous polymeric hydrogel microparticles
|
|
JP2019524651A
(ja)
|
2016-06-08 |
2019-09-05 |
アッヴィ・インコーポレイテッド |
抗ｃｄ９８抗体及び抗体薬物コンジュゲート
|
|
WO2017214322A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
|
AU2017279550A1
(en)
|
2016-06-08 |
2019-01-03 |
Abbvie Inc. |
Anti-B7-H3 antibodies and antibody drug conjugates
|
|
JP2019534859A
(ja)
|
2016-09-19 |
2019-12-05 |
セルジーン コーポレイション |
Ｐｄ−１結合タンパク質を使用して白斑を治療する方法
|
|
MX2019002867A
(es)
|
2016-09-19 |
2019-11-12 |
Celgene Corp |
Metodos de tratamiento de trastornos inmunologicos usando proteinas de union a pd-1.
|
|
CA3039195A1
(en)
*
|
2016-10-10 |
2018-04-19 |
Abraxis Bioscience, Llc |
Nanoparticle formulations and methods of making and using thereof
|
|
EP3534947A1
(de)
|
2016-11-03 |
2019-09-11 |
Kymab Limited |
Antikörper, kombinationen mit antikörpern, biomarker, verwendungen und verfahren
|
|
EP3544628A4
(de)
|
2016-11-23 |
2020-11-18 |
Immunoah Therapeutics, Inc. |
4-1bb-bindende proteine und verwendungen davon
|
|
WO2018106998A1
(en)
*
|
2016-12-08 |
2018-06-14 |
Massachusetts Institute Of Technology |
Compositions and related methods for targeted drug delivery
|
|
JOP20190187A1
(ar)
|
2017-02-03 |
2019-08-01 |
Novartis Ag |
مترافقات عقار جسم مضاد لـ ccr7
|
|
ES3036482T3
(en)
|
2017-03-11 |
2025-09-19 |
Cartesian Therapeutics Inc |
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
|
|
EP3600324A4
(de)
|
2017-03-23 |
2020-12-09 |
Graybug Vision, Inc. |
Arzneimittel und zusammensetzungen zur behandlung von augenkrankheiten
|
|
WO2018185618A1
(en)
|
2017-04-03 |
2018-10-11 |
Novartis Ag |
Anti-cdh6 antibody drug conjugates and anti-gitr antibody combinations and methods of treatment
|
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
|
AU2018265415A1
(en)
|
2017-05-10 |
2019-10-31 |
Graybug Vision, Inc. |
Extended release microparticles and suspensions thereof for medical therapy
|
|
CN111051346A
(zh)
|
2017-05-31 |
2020-04-21 |
斯特库伯株式会社 |
使用免疫特异性结合btn1a1的抗体和分子治疗癌症的方法
|
|
KR20200015602A
(ko)
|
2017-05-31 |
2020-02-12 |
주식회사 에스티큐브앤컴퍼니 |
Btn1a1에 면역특이적으로 결합하는 항체 및 분자 및 이의 치료적 용도
|
|
KR20200026209A
(ko)
|
2017-06-06 |
2020-03-10 |
주식회사 에스티큐브앤컴퍼니 |
Btn1a1 또는 btn1a1-리간드에 결합하는 항체 및 분자를 사용하여 암을 치료하는 방법
|
|
CN111132666B
(zh)
*
|
2017-07-25 |
2022-11-04 |
雷莫内克斯生物制药有限公司 |
用于将生理活性成分递送至血管的组合物
|
|
CA3083363A1
(en)
|
2017-12-01 |
2019-06-06 |
Novartis Ag |
Polyomavirus neutralizing antibodies
|
|
CN111615520A
(zh)
|
2017-12-01 |
2020-09-01 |
辉瑞大药厂 |
抗cxcr5抗体及其组合物和用途
|
|
BR112020017701A2
(pt)
|
2018-03-12 |
2020-12-29 |
Zoetis Services Llc |
Anticorpos anti-ngf e métodos dos mesmos
|
|
KR102088663B1
(ko)
*
|
2018-03-20 |
2020-03-13 |
한국세라믹기술원 |
친수성 및 소수성 약물의 동시 전달을 위한 온도민감성 나노스펀지 플랫폼 및 이의 용도
|
|
PE20211235A1
(es)
|
2018-03-29 |
2021-07-08 |
Univ California |
Variantes de lfa3 y composiciones y usos de las mismas
|
|
US10633458B2
(en)
|
2018-04-10 |
2020-04-28 |
Y-Biologics Inc. |
Cell engaging binding molecules
|
|
WO2019209883A1
(en)
*
|
2018-04-23 |
2019-10-31 |
Graybug Vision, Inc. |
Improved continuous microparticle manufacture
|
|
EP3801766A1
(de)
|
2018-05-31 |
2021-04-14 |
Novartis AG |
Hepatitis-b-antikörper
|
|
KR102870868B1
(ko)
|
2018-06-01 |
2025-10-15 |
노파르티스 아게 |
Bcma에 대한 결합 분자 및 이의 용도
|
|
EP3806889A4
(de)
|
2018-06-18 |
2022-07-13 |
Anwita Biosciences, Inc. |
Zytokinfusionsproteine und verwendungen davon
|
|
CN112740043A
(zh)
|
2018-07-20 |
2021-04-30 |
皮埃尔法布雷医药公司 |
Vista受体
|
|
JP7654539B2
(ja)
|
2018-09-07 |
2025-04-01 |
ファイザー・インク |
抗αｖβ８抗体、組成物及びその使用
|
|
WO2020053742A2
(en)
|
2018-09-10 |
2020-03-19 |
Novartis Ag |
Anti-hla-hbv peptide antibodies
|
|
BR112021005585A2
(pt)
|
2018-09-27 |
2021-06-29 |
Celgene Corporation |
proteínas de ligação a sirpa e métodos de uso das mesmas
|
|
CA3114176A1
(en)
|
2018-09-28 |
2020-04-02 |
Jochen Reiser |
Supar and prediction and treatment of acute kidney injury
|
|
TW202039554A
(zh)
|
2018-12-19 |
2020-11-01 |
瑞士商諾華公司 |
抗ＴＮＦ－α抗體
|
|
KR20210107731A
(ko)
|
2018-12-21 |
2021-09-01 |
노파르티스 아게 |
Pmel17에 대한 항체 및 이의 접합체
|
|
US12178939B2
(en)
|
2019-01-31 |
2024-12-31 |
Cell-Medicine, Inc. |
Inorganic salt-protein composite medical instrument
|
|
EP3936501B1
(de)
|
2019-03-08 |
2025-12-31 |
ABTIS Co., Ltd. |
Ortsspezifische antikörper-konjugation und antikörper-wirkstoff-konjugat als spezifisches beispiel dafür
|
|
WO2020205827A1
(en)
|
2019-04-01 |
2020-10-08 |
Rush University Medical Center |
Reagents and assays using modified integrin domains
|
|
TW202102526A
(zh)
|
2019-04-04 |
2021-01-16 |
美商銳進科斯生物股份有限公司 |
重組腺相關病毒及其用途
|
|
AU2020287627A1
(en)
|
2019-06-04 |
2021-11-18 |
Selecta Biosciences, Inc. |
Formulations and doses of PEGylated uricase
|
|
EP4004214A1
(de)
|
2019-07-26 |
2022-06-01 |
RegenxBio Inc. |
Gentechnisch hergestelltes nukleinsäureregulationselement und verwendungsverfahren dafür
|
|
US20220411511A1
(en)
|
2019-09-26 |
2022-12-29 |
Stcube & Co. |
Antibodies specific to glycosylated ctla-4 and methods of use thereof
|
|
EP4041768A1
(de)
|
2019-10-09 |
2022-08-17 |
StCube & Co. |
Spezifische antikörper gegen glykosiertes lag3 und verfahren zur verwendung davon
|
|
JP7600528B2
(ja)
|
2020-03-16 |
2024-12-17 |
株式会社リコー |
粒子の製造方法
|
|
US20230181756A1
(en)
|
2020-04-30 |
2023-06-15 |
Novartis Ag |
Ccr7 antibody drug conjugates for treating cancer
|
|
CN115461363A
(zh)
|
2020-05-01 |
2022-12-09 |
诺华股份有限公司 |
免疫球蛋白变体
|
|
CN116096758A
(zh)
|
2020-05-01 |
2023-05-09 |
诺华股份有限公司 |
工程化免疫球蛋白
|
|
KR20230012539A
(ko)
|
2020-05-13 |
2023-01-26 |
디스크 메디슨, 인크. |
골수섬유증을 치료하기 위한 항-헤모주벨린 (hjv) 항체
|
|
KR20230025005A
(ko)
|
2020-06-17 |
2023-02-21 |
얀센 바이오테크 인코포레이티드 |
만능 줄기세포의 제조를 위한 재료 및 방법
|
|
JP7846667B2
(ja)
|
2020-07-16 |
2026-04-15 |
レジェンド バイオテック アイルランド リミテッド |
Ｃｄ２０結合分子及びその使用
|
|
JP2023537470A
(ja)
|
2020-08-03 |
2023-09-01 |
ヤンセン バイオテツク，インコーポレーテツド |
ウイルス治療における多方向バイオ輸送のための材料及び方法
|
|
CA3190987A1
(en)
|
2020-08-10 |
2022-02-17 |
Janssen Biotech, Inc. |
Materials and methods for producing bioengineered virus specific lymphocytes
|
|
CN114073791B
(zh)
*
|
2020-08-21 |
2022-05-31 |
中国科学院化学研究所 |
一种软骨组织工程支架及其制备方法与应用
|
|
WO2022072597A1
(en)
*
|
2020-09-30 |
2022-04-07 |
Diomics Corporation |
Transdermal medicament delivery device
|
|
MX2023003699A
(es)
|
2020-10-07 |
2023-04-21 |
Regenxbio Inc |
Virus adenoasociados para el suministro ocular de genoterapia.
|
|
WO2022076750A2
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns or muscle delivery
|
|
US20240002509A1
(en)
|
2020-11-06 |
2024-01-04 |
Novartis Ag |
ANTIBODY Fc VARIANTS
|
|
IL302412A
(en)
|
2020-11-06 |
2023-06-01 |
Novartis Ag |
Anti-CD19 and B-cell targeting agent combination therapy for the treatment of B-cell malignancies
|
|
CA3199095A1
(en)
|
2020-11-06 |
2022-05-12 |
Novartis Ag |
Cd19 binding molecules and uses thereof
|
|
JP2024502832A
(ja)
|
2020-12-31 |
2024-01-23 |
アラマー バイオサイエンシーズ， インコーポレイテッド |
高親和性及び／または特異性を有する結合剤分子ならびにその製造及び使用方法
|
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
US12404439B2
(en)
|
2021-03-29 |
2025-09-02 |
Championx Llc |
Extended release asphaltene inhibitor composition
|
|
BR112023021475A2
(pt)
|
2021-04-16 |
2023-12-19 |
Novartis Ag |
Conjugados anticorpo-fármaco e métodos para produzir os mesmos
|
|
WO2023060272A2
(en)
|
2021-10-07 |
2023-04-13 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns tropic delivery
|
|
WO2023060269A1
(en)
|
2021-10-07 |
2023-04-13 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for targeted delivery
|
|
CN118119642A
(zh)
|
2021-10-28 |
2024-05-31 |
诺华股份有限公司 |
工程化Fc变体
|
|
US20250025574A1
(en)
|
2021-10-28 |
2025-01-23 |
Regenxbio Inc. |
Engineered nucleic acid regulatory elements and methods and uses thereof
|
|
UY40097A
(es)
|
2022-01-07 |
2023-07-14 |
Johnson & Johnson Entpr Innovation Inc |
Materiales y métodos de proteínas de unión a il-1b
|
|
WO2023152633A1
(en)
|
2022-02-09 |
2023-08-17 |
Janssen Biotech, Inc. |
Methods and compositions comprising v beta 17 bispecific t cell engagers and bioengineered virus specific lymphocytes
|
|
WO2023178053A1
(en)
|
2022-03-13 |
2023-09-21 |
Regenxbio Inc. |
Modified muscle-specific promoters
|
|
WO2023201277A1
(en)
|
2022-04-14 |
2023-10-19 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns tropic delivery
|
|
US20250249127A1
(en)
|
2022-04-14 |
2025-08-07 |
Regenxbio Inc. |
Gene therapy for treating an ocular disease
|
|
US20250277004A1
(en)
|
2022-04-18 |
2025-09-04 |
Regenxbio Inc. |
Hybrid aav capsids
|
|
IL316174A
(en)
|
2022-04-26 |
2024-12-01 |
Novartis Ag |
Multiple specific antibodies targeting IL-13 and IL-18
|
|
JP2025525530A
(ja)
|
2022-07-15 |
2025-08-05 |
ヤンセン バイオテツク，インコーポレーテツド |
抗原結合可変領域の改善された生物工学による対合のための材料及び方法
|
|
CN115006605A
(zh)
*
|
2022-07-20 |
2022-09-06 |
苏州中天医疗器械科技有限公司 |
一种药物涂层球囊及其制备方法和应用
|
|
WO2024018426A1
(en)
|
2022-07-22 |
2024-01-25 |
Janssen Biotech, Inc. |
Enhanced transfer of genetic instructions to effector immune cells
|
|
CA3263779A1
(en)
|
2022-08-05 |
2024-02-08 |
Janssen Biotech, Inc. |
CD98 LINKAGE CONSTRUCTIONS FOR THE TREATMENT OF BRAIN TUMORS
|
|
MA71684A
(fr)
|
2022-08-05 |
2025-05-30 |
Janssen Biotech, Inc. |
Protéines de liaison de récepteur de transferrine pour traitement de tumeurs cérébrales
|
|
US20260055144A1
(en)
|
2022-08-24 |
2026-02-26 |
Regenxbio Inc. |
Recombinant adeno-associated viruses and uses thereof
|
|
WO2024073492A1
(en)
*
|
2022-09-28 |
2024-04-04 |
Championx Llc |
Extended release asphaltene inhibitor composition
|
|
EP4601710A2
(de)
|
2022-10-11 |
2025-08-20 |
RegenxBio Inc. |
Manipulierte regulatorische nukleinsäureelemente sowie verfahren und verwendungen davon
|
|
CN116211732B
(zh)
*
|
2023-01-03 |
2023-11-17 |
广州澳特朗生物技术有限公司 |
一种具有组织修护、抗皱和舒缓功效的纤连蛋白纳米制剂及其制备方法和应用
|
|
WO2024182767A1
(en)
|
2023-03-01 |
2024-09-06 |
Provention Bio, Inc. |
Methods and compositions for treating type 1 diabetes comprising teplizumab and verapamil
|
|
TW202506177A
(zh)
|
2023-03-30 |
2025-02-16 |
美商普泛森生技公司 |
減少外源性胰島素使用之方法
|
|
WO2024216244A2
(en)
|
2023-04-13 |
2024-10-17 |
Regenxbio Inc. |
Targeting aav capsids, methods of manufacturing and using same
|
|
WO2024238853A1
(en)
|
2023-05-16 |
2024-11-21 |
Regenxbio Inc. |
Adeno-associated viruses for ocular delivery of gene therapy
|
|
AU2024299422A1
(en)
|
2023-07-27 |
2026-03-12 |
Provention Bio, Inc. |
Methods for treating type 1 diabetes
|
|
CN116874996B
(zh)
*
|
2023-09-01 |
2023-12-05 |
山东龙兴塑膜科技股份有限公司 |
一种改性聚酯的制备方法及在覆膜铁用聚酯薄膜中的应用
|
|
WO2025108407A2
(en)
|
2023-11-23 |
2025-05-30 |
Neuexcell Therapeutics (Suzhou) Co., Ltd. |
Gene therapy compositions and methods for treating glioma
|
|
WO2025217214A2
(en)
|
2024-04-08 |
2025-10-16 |
Regenxbio Inc. |
Recombinant adeno-associated viruses and uses thereof
|
|
WO2025262564A1
(en)
|
2024-06-17 |
2025-12-26 |
Pfizer Inc. |
Use of anti-cxcr5 antibodies
|
|
WO2026058155A1
(en)
|
2024-09-11 |
2026-03-19 |
Novartis Ag |
Antibodies targeting il-31
|
|
CN120681889B
(zh)
*
|
2025-06-24 |
2025-12-12 |
广东工业大学 |
一种利用微生物菌剂快速降解湖泊水体难降解溶解性有机物的方法
|